1. Home
  2. AUDC vs VYGR Comparison

AUDC vs VYGR Comparison

Compare AUDC & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.36

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
VYGR
Founded
1992
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.0M
226.8M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
AUDC
VYGR
Price
$8.36
$3.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$11.67
$17.00
AVG Volume (30 Days)
73.0K
516.9K
Earning Date
02-03-2026
11-10-2025
Dividend Yield
4.62%
N/A
EPS Growth
15.76
N/A
EPS
0.46
N/A
Revenue
$244,553,000.00
$31,316,000.00
Revenue This Year
$2.98
N/A
Revenue Next Year
$3.40
$71.78
P/E Ratio
$18.61
N/A
Revenue Growth
0.15
N/A
52 Week Low
$8.01
$2.65
52 Week High
$12.72
$5.96

Technical Indicators

Market Signals
Indicator
AUDC
VYGR
Relative Strength Index (RSI) 32.95 39.01
Support Level $8.71 $3.81
Resistance Level $8.94 $4.24
Average True Range (ATR) 0.20 0.21
MACD -0.04 -0.02
Stochastic Oscillator 3.41 6.73

Price Performance

Historical Comparison
AUDC
VYGR

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: